Ichnos Sciences Inc., a global biotechnology company developing innovative multispecific antibodies for oncology, today announced the formation of its Scientific Advisory Board (SAB) comprised of experts in oncology, immunology, protein engineering, drug discovery and development.
February 28, 2022
· 6 min read